Agios Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (25)

Latest Posts

About This Stock More About This Stock
Biotechs Hold And Ignore Rocky Week Of Global Politics - Big Earnings Upcoming… Updates CELG, BIIB, AZN, XBI
Article By: Rod Raynovich
Saturday, July 28, 2018 9:15 PM EDT
Biotech and Tech stocks teetered near highs for the year despite all the political drama of Putin and Trump at Helsinki, Russian “Spy” at the NRA, Tariffs and Trade War, Brexit Uncertainty, currency volatility and the Powell FED rate hike policy.
In this article: AZN, BIIB, LLY, CELG, RHHBY, VRTX, BMY, AMGN, GILD, ABBV, HON, JNJ, AGIO
Read
Week In Review: CStone Acquires China Rights To Leukemia Drug In $424 Million Deal
Article By: ChinaBio® Today
Saturday, June 30, 2018 4:25 PM EDT
CStone Pharma of Suzhou acquired rights to a novel cancer drug from Agios in a deal worth up to $424 million. CStone will have rights to ivosidenib in greater China. It will initially target acute myeloid leukemia (AML) and cholangiocarcinoma.
In this article: AGIO, LGND, NVS, ZLAB
Read
Biotech Stocks Emerge Unscathed And Ready To Go
Article By: Tarun Chandra, CFA
Friday, May 18, 2018 8:41 PM EDT
The biotech stocks have been demonstrating strong resilience in the face of intense volatility since February and, remarkably, keeping pace with the broader indexes, considering the highly speculative and volatile nature of the group.
In this article: CVS, MRK, IBB, INCY, ESRX, XBI, ARNA, ECYT, IMMU, IRWD, DVAX, SUPN, SRPT, AGIO, QURE, HRTX, LOXO, ATRA, BGNE, ADAP, CRSP, CBIO, GTHX, MRTX
Read
Biotechs Bounce Off Bottom On Novartis Deal But Fade Later In The Day
Article By: Rod Raynovich
Monday, April 9, 2018 7:49 PM EDT
Normally this kind of M&A news would be an opportunity to load up on biotechs but technicals are still weak and crosscurrents from economic and macro news create a risk-off sentiment.
In this article: NVS, FBT, AGIO, AVXS Also: IBB, SGMO, XBI, BLUE, ONCE, CLLS, EDIT, NTLA, CRSP
Read
4 Medical Product Stocks Likely To Top Q2 Earnings Estimates
Article By: Zacks Investment Research
Monday, August 7, 2017 5:52 PM EDT
With the existence of a number of industry players, finding the right stocks that have the potential to beat earnings could be a daunting task.
In this article: XRAY, AGIO, NVTR, DXTR
Read

PARTNER HEADLINES

Latest Tweets for $AGIO

No tweets yet!